Tax

Foreign Tax (Current)

Vertex Pharmaceuticals Foreign Tax (Current) remained flat by 0.0% to $121.45M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 56.8%, from $77.45M to $121.45M. Over 2 years (FY 2023 to FY 2025), Foreign Tax (Current) shows an upward trend with a 17.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionTax
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

Fluctuations often correlate with changes in international profitability or shifts in foreign tax regulatory environments.

Detailed definition

The portion of the total income tax provision that is currently payable to foreign governments based on international ea...

Peer comparison

Standard for multinational firms; used to evaluate the impact of global tax strategies.

Metric ID: is_msft_current_foreign_tax_expense

Historical Data

3 years
 FY'23FY'24FY'25
Value$350.10M$309.80M$485.80M
YoY Change—-11.5%+56.8%
Range$309.80M – $485.80M
CAGR+17.8%
Avg YoY Growth+22.6%
Median YoY Growth+22.6%

Frequently Asked Questions

What is Vertex Pharmaceuticals's foreign tax (current)?
Vertex Pharmaceuticals (VRTX) reported foreign tax (current) of $121.45M in Q4 2025.
How has Vertex Pharmaceuticals's foreign tax (current) changed year-over-year?
Vertex Pharmaceuticals's foreign tax (current) increased by 56.8% year-over-year, from $77.45M to $121.45M.
What is the long-term trend for Vertex Pharmaceuticals's foreign tax (current)?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's foreign tax (current) has grown at a 17.8% compound annual growth rate (CAGR), from $350.10M to $485.80M.
What does foreign tax (current) mean?
The amount of income tax currently owed to foreign governments for the period.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.